A Phase 1b/2 Study to Evaluate the Effect of AsiDNA in Combination with Radiotherapy in Children with Recurrent High-Grade Glioma (HGG) Eligible for Re-Irradiation
Latest Information Update: 11 Nov 2023
At a glance
- Drugs Etidaligide (Primary)
- Indications Glioma
- Focus Proof of concept; Therapeutic Use
- 24 Apr 2023 According to an Onxeo SA media release, clinical updates of this study is expected in the second half of 2023.
- 26 Apr 2021 New trial record